0001628280-20-009547.txt : 20200616 0001628280-20-009547.hdr.sgml : 20200616 20200616164740 ACCESSION NUMBER: 0001628280-20-009547 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200615 FILED AS OF DATE: 20200616 DATE AS OF CHANGE: 20200616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Huber Reid M CENTRAL INDEX KEY: 0001607052 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36783 FILM NUMBER: 20966966 MAIL ADDRESS: STREET 1: C/O INCYTE CORPORATION, EXPERIMENTAL STN STREET 2: ROUTE 141 & HENRY CLAY ROAD, BLDG. E336 CITY: WILMINGTON STATE: DE ZIP: 19880 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0001358403 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201450200 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2130 WEST HOLCOMBE BOULEVARD STREET 2: SUITE 800 CITY: HOUSTON STATE: TX ZIP: 77030 BUSINESS PHONE: (832) 384-1100 MAIL ADDRESS: STREET 1: 2130 WEST HOLCOMBE BOULEVARD STREET 2: SUITE 800 CITY: HOUSTON STATE: TX ZIP: 77030 FORMER COMPANY: FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060405 4 1 wf-form4_159234044255883.xml FORM 4 X0306 4 2020-06-15 0 0001358403 BELLICUM PHARMACEUTICALS, INC BLCM 0001607052 Huber Reid M C/O BELLICUM PHARMACEUTICALS, INC. 2130 W. HOLCOMBE BLVD., STE. 800 HOUSTON TX 77030 1 0 0 0 Stock Option (right to buy) 8.42 2020-06-15 4 A 0 6500 0 A 2030-06-14 Common Stock 6500.0 6500 D The shares subject to the option vest and become exercisable in full on the one-year anniversary of the grant date. /s/ Shane M. Ward, Attorney-in-Fact 2020-06-16